These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 23198915)

  • 1. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.
    Zhao Y; Fu L; Li R; Wang LN; Yang Y; Liu NN; Zhang CM; Wang Y; Liu P; Tu BB; Zhang X; Qiao J
    BMC Med; 2012 Nov; 10():153. PubMed ID: 23198915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls.
    Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
    Biol Sex Differ; 2023 Sep; 14(1):62. PubMed ID: 37736753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
    Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
    Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic heterogeneity of follicular amino acids in polycystic ovary syndrome is affected by obesity and related to pregnancy outcome.
    Zhang CM; Zhao Y; Li R; Yu Y; Yan LY; Li L; Liu NN; Liu P; Qiao J
    BMC Pregnancy Childbirth; 2014 Jan; 14():11. PubMed ID: 24410809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance.
    Chen YX; Zhang XJ; Huang J; Zhou SJ; Liu F; Jiang LL; Chen M; Wan JB; Yang DZ
    J Pharm Biomed Anal; 2016 Mar; 121():141-150. PubMed ID: 26808063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics and correlation network analysis of follicular fluid reveals associations between l-tryptophan, l-tyrosine and polycystic ovary syndrome.
    Hou E; Zhao Y; Hang J; Qiao J
    Biomed Chromatogr; 2021 Mar; 35(3):e4993. PubMed ID: 32986877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS.
    Escobar-Morreale HF; Samino S; Insenser M; Vinaixa M; Luque-Ramírez M; Lasunción MA; Correig X
    Clin Chem; 2012 Jun; 58(6):999-1009. PubMed ID: 22427353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique.
    Buszewska-Forajta M; Rachoń D; Stefaniak A; Wawrzyniak R; Konieczna A; Kowalewska A; Markuszewski MJ
    J Steroid Biochem Mol Biol; 2019 Feb; 186():176-184. PubMed ID: 30670174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome.
    Selen ES; Bolandnazar Z; Tonelli M; Bütz DE; Haviland JA; Porter WP; Assadi-Porter FM
    J Proteome Res; 2015 Aug; 14(8):3284-91. PubMed ID: 26076986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of Branched-Chain and Aromatic Amino Acid Profile as a Novel Approach in Studying Polycystic Ovary Syndrome Pathogenesis.
    Paczkowska K; Rachoń D; Berg A; Rybka J; Kapczyńska K; Bolanowski M; Daroszewski J
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum metabolomics of Indian women with polycystic ovary syndrome using
    RoyChoudhury S; Mishra BP; Khan T; Chattopadhayay R; Lodh I; Datta Ray C; Bose G; Sarkar HS; Srivastava S; Joshi MV; Chakravarty B; Chaudhury K
    Mol Biosyst; 2016 Oct; 12(11):3407-3416. PubMed ID: 27714060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients.
    Sun L; Hu W; Liu Q; Hao Q; Sun B; Zhang Q; Mao S; Qiao J; Yan X
    J Proteome Res; 2012 May; 11(5):2937-46. PubMed ID: 22428626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid signatures in relation to polycystic ovary syndrome and increased risk of different metabolic disturbances.
    Ye Z; Zhang C; Wang S; Zhang Y; Li R; Zhao Y; Qiao J
    Reprod Biomed Online; 2022 Apr; 44(4):737-746. PubMed ID: 35131170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach.
    Zhang XJ; Huang LL; Su H; Chen YX; Huang J; He C; Li P; Yang DZ; Wan JB
    J Pharm Biomed Anal; 2014 Jul; 95():85-92. PubMed ID: 24637052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment.
    Zhao T; Xiao X; Li L; Zhu J; He W; Zhang Q; Wu J; Wu X; Yuan T
    Front Endocrinol (Lausanne); 2024; 15():1354214. PubMed ID: 38948525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in whole metabolites after exenatide treatment in overweight/obese polycystic ovary syndrome patients.
    Tang L; Yuan L; Yang G; Wang F; Fu M; Chen M; Liu D
    Clin Endocrinol (Oxf); 2019 Oct; 91(4):508-516. PubMed ID: 31271659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes.
    Zhou W; Hong Y; Yin A; Liu S; Chen M; Lv X; Nie X; Tan N; Zhang Z
    J Pharm Biomed Anal; 2020 Jun; 185():113262. PubMed ID: 32222648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
    Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.